Table 2 S100A2 expression associated with clinicopathologic characteristics (logistic regression)
From: High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma
Characteristics | Total(N) | Odds Ratio(OR) | P value |
|---|---|---|---|
Clinical stage (Stage IV&Stage III vs. Stage I&Stage II) | 552 | 1.505 (1.039-2.186) | 0.031 |
Primary therapy outcome (PD&SD&PR vs. CR) | 480 | 0.973 (0.499-1.897) | 0.936 |
Weight (>80 vs. <=80) | 528 | 1.079 (0.766-1.520) | 0.662 |
Age (>60 vs. <=60) | 549 | 0.934 (0.661-1.320) | 0.700 |
BMI (>30 vs. <=30) | 519 | 1.266 (0.892-1.800) | 0.187 |
Histological type (Serous&Mix vs. Endometrioid) | 552 | 1.778 (1.209-2.632) | 0.004 |
Histologic grade (G3 vs. G1&G2) | 541 | 1.173 (0.832-1.656) | 0.362 |
Residual tumor (R1&R2 vs. R0) | 413 | 1.007 (0.512-1.967) | 0.984 |
Tumor invasion(%) (>=50 vs. <50) | 474 | 1.188 (0.827-1.707) | 0.352 |
Menopause status (Peri&Post vs. Pre) | 506 | 2.078 (1.028-4.408) | 0.047 |
Diabetes (Yes vs. No) | 451 | 0.725 (0.477-1.098) | 0.129 |